Compare iShares Core Growth Allocation ETF (AOR) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core Growth Allocation ETF vs Quest Diagnostics Inc — how do they compare? iShares Core Growth Allocation ETF trades at $69.87, while Quest Diagnostics Inc trades at $237.5 (market cap $26.21B). The key difference: Quest Diagnostics Inc pays a 1.45% dividend while iShares Core Growth Allocation ETF pays none. Which is the better fit depends on your goals.
| AOR | DGX | |
|---|---|---|
52-Week High | $70.12 | $238.50 |
52-Week Low | $62.26 | $173.49 |
Market Cap | — | $26.21B |
Sector | — | Health |
Enterprise Value | — | $31.97B |
Dividend Yield | — | 1.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares Core Growth Allocation ETF
The fund is a fund of funds and seeks its investment objective by investing primarily in underlying funds that themselves seek investment results corresponding to their own respective underlying indexes. It generally will invest at least 80% of its assets in the component securities of its underlying index. The index measures the performance of the S&P Dow Jones Indices LLC proprietary allocation model.
Read more on AOR →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
